Beyond secondline therapy New hope for mCRC patients in Egypt

Beyond second-line therapy: New hope for mCRC patients in Egypt

06:02 EDT 9 May 2019 | ecancermedicalscience

Prof Heinz-Josef Lenz speaks to ecancer at the 2019 International Gastrointestinal, Liver and Uro-Oncology Conference (IGILUC) in Cairo about the use of TAS-102 for the treatment of metastatic colorectal cancer (mCRC) in Egypt. Prof Lenz discusses the...

Original Article: Beyond second-line therapy: New hope for mCRC patients in Egypt

More From BioPortfolio on "Beyond second-line therapy: New hope for mCRC patients in Egypt"